 |
Gemtuzumab ozogamicin |
|---|---|
| Trade Name | Mylotarg |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1999-11-24 00:00:00 |
| Sponsor | Wyeth Pharmaceuticals, Inc., a Pfizer Company;10646 Science Center Drive;San Diego, California, 92121 |
